Vaxart (VXRT) EV to CFO (2014 - 2026)
Vaxart's (VXRT) EV to CFO stood at 2.48 in Q2 2026, down 56.4% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) EV to CFO (2014 - 2026) Analysis & Trends
For FY2025, Vaxart's EV to CFO came in at 2.64.
- The Q2 2026 figure is the lowest quarterly EV to CFO since Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Vaxart | 115.76 Mn | 51.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 |
| Mar 31, 2026 | 5.68 |
| Dec 31, 2025 | 2.64 |
| Sep 30, 2018 | 0.20 |
| Jun 30, 2018 | -0.17 |
| Mar 31, 2018 | 1.07 |
| Dec 31, 2017 | 5.63 |
| Sep 30, 2015 | 6.66 |
| Mar 31, 2015 | 9.11 |
| Dec 31, 2014 | 11.18 |
API Access
Vaxart EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();